Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4159982
Max Phase: Preclinical
Molecular Formula: C21H23NO2S
Molecular Weight: 353.49
Molecule Type: Small molecule
Associated Items:
ID: ALA4159982
Max Phase: Preclinical
Molecular Formula: C21H23NO2S
Molecular Weight: 353.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOCc1cnc2ccc(OCc3ccccc3)cc2c1SCC
Standard InChI: InChI=1S/C21H23NO2S/c1-3-23-15-17-13-22-20-11-10-18(12-19(20)21(17)25-4-2)24-14-16-8-6-5-7-9-16/h5-13H,3-4,14-15H2,1-2H3
Standard InChI Key: NIUHYVMDRWBKEX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 353.49 | Molecular Weight (Monoisotopic): 353.1449 | AlogP: 5.46 | #Rotatable Bonds: 8 |
Polar Surface Area: 31.35 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 4.30 | CX LogP: 4.81 | CX LogD: 4.81 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.50 | Np Likeness Score: -1.00 |
1. Goncalves V, Brannigan JA, Laporte A, Bell AS, Roberts SM, Wilkinson AJ, Leatherbarrow RJ, Tate EW.. (2017) Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase., 8 (1): [PMID:28626547] [10.1039/C6MD00531D] |
Source(1):